The ACC and Veradigm Inc. have announced a new "TRANSFORM VAX" initiative aimed at improving cardiovascular health through increased influenza vaccination education. Powered by Veradigm de-identified real-world data, TRANSFORM VAX will deliver educational messaging to health care providers whose patient cohorts meet ACC-determined criteria for inclusion. It will then compare results against a control group of physicians not receiving TRANSFORM VAX messaging, enabling the ACC to establish benchmarks from which to measure future quality improvement success. Learn more.